Indeed, shiga toxin inhibits major complement regulators, complement Factor H (CFH) and CFH-related proteins, mimicking effects caused by the loss-of-function mutations observed in atypical HUS [2,13,14]. This evidence concerns the gene CFH and hemolytic-uremic syndrome.